Transplant Diagnostics Market
Transplant Diagnostics Market by Product & Service (Instrument, Software), Technology (PCR, NGS), Application [Diagnostic (Infectious Disease, HLA) Research], Type [Solid Organ (Heart), Bone Marrow], End User (Hospital) & Region -Global Forecast to 2031
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The transplant diagnostics market is expected to reach USD 8.14 billion by 2031 from USD 5.61 billion in 2026, at a CAGR of 7.8% during the forecast period. The primary factors driving the growth of this market include the increasing number of organ transplantation procedures and the rising prevalence of chronic diseases requiring transplantation. The growing demand for accurate donor-recipient compatibility testing, histocompatibility testing, infectious disease testing, and blood profiling is further supporting market growth. Increasing research and development investments have resulted in significant advancements in molecular diagnostic technologies, including PCR and next-generation sequencing (NGS). Other major growth drivers include rising public and private investments and increasing government initiatives aimed at strengthening transplantation and diagnostic infrastructure.
KEY TAKEAWAYS
-
BY REGIONBy region, North America leads the market in 2025.
-
BY PRODUCT & SERVICEBy product & service, the reagents & consumables segment is expected to register the highest growth rate during the forecast period.
-
BY TECHNOLOGYBy technology, the molecular assays segment held the largest market share of 89.7% in 2025.
-
BY APPLICATIONBy application, diagnostic applications are expected to grow at the highest CAGR during the forecast period.
-
BY TYPEBy type, solid organ transplantation leads the market with a share of 90.9% in 2025.
-
BY END USERBy end user, independent reference laboratories are expected to grow at the highest rate.
-
COMPETITIVE LANDSCAPE - KEY PLAYERSThermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), and bioMérieux (France) were identified in the transplant diagnostics market as star players, which correspondingly is supported by their strong market presence and extensive product portfolios.
-
COMPETITIVE LANDSCAPE - STARTUPS/SMEsScisco Genetics, Inc. (US), inno-train Diagnostik GmbH (Germany), Bionobis (France), Takara Bio Inc. (Japan), Krishgen Biosystems Private Limited (India), and Prolmmune Ltd. (UK)have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas.
The transplant diagnostics market is expected to witness significant growth due to the increasing number of transplant procedures and the rising prevalence of infectious diseases requiring accurate donor-recipient compatibility testing. Molecular diagnostic technologies, including PCR and next-generation sequencing (NGS), have experienced rapid advancements and are contributing to improved efficiency, accuracy, and turnaround time of transplant diagnostic procedures. Furthermore, increasing public-private funding and growing investments in transplant research are supporting research and development activities, which are expected to accelerate the adoption of advanced transplant diagnostic technologies and support market expansion during the forecast period.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The growing number of organ transplantation procedures, along with advancements in molecular diagnostic technologies, has led to an increased demand for transplant diagnostic testing. These diagnostic procedures are essential for assessing donor-recipient compatibility, conducting histocompatibility testing, screening for infectious diseases, and performing blood profiling during transplantation. As techniques such as PCR and next-generation sequencing (NGS) become more widely used, we can expect a higher adoption rate of advanced transplant diagnostic technologies. Additionally, the rise in public and private funding, increased investments in transplant research, and improvements in laboratory technologies are anticipated to enhance the efficiency and accuracy of transplant diagnostic procedures, ultimately supporting market growth.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Increasing number of transplant procedures
-
Advancements in molecular diagnostic technologies
Level
-
High cost of advanced molecular diagnostic techniques
-
Limited access to advanced transplant diagnostic infrastructure in emerging economies
Level
-
Increasing adoption of cross-matching and chimerism testing
-
Growing awareness regarding organ donation and transplantation
Level
-
Gap between organ donor availability and transplant demand
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Increasing number of transplant procedures
The increasing number of transplant procedures is a significant factor driving the growth of the transplant diagnostics market. The global aging population and the rising prevalence of chronic diseases, such as end-stage renal disease (ESRD), liver cirrhosis, and other organ disorders, are amplifying the demand for organ and tissue transplantation. Recent transplantation statistics indicate that kidney transplants have the highest number of patients on the waiting list, totaling 89,792, followed by liver transplants with 9,424 patients and heart transplants with 3,456 patients. In 2024, over 48,000 transplants were performed. As the number of transplantation procedures and prospective donors grows, there is an increasing demand for donor-recipient profiling, histocompatibility testing, and compatibility testing to minimize the risk of immune rejection.
Restraint: High cost of advanced molecular diagnostic techniques
The high cost of advanced molecular diagnostic techniques is limiting the growth of the transplant diagnostics market. Procedures such as histocompatibility testing, infectious disease testing, and blood profiling require specialized platforms based on PCR and NGS technologies, which are often integrated with automation and microfluidic systems. However, the substantial capital investments and research expenditures associated with these technologies lead to high instrument and procedural costs. This, in turn, increases the financial burden on healthcare providers and patients.
Opportunity: Growing awareness regarding organ donation and transplantation
Growing public awareness about organ donation and transplantation is expected to create significant growth opportunities for the transplant diagnostics market. Organ transplantation is increasingly recognized as an effective treatment option for chronic and terminal diseases such as cancer, chronic kidney disease, and heart disease. The rising prevalence of these conditions is driving the demand for organ transplantation procedures worldwide. Furthermore, the increasing number of patients on organ donation waiting lists and heightened awareness of successful transplantation outcomes are further contributing to market growth. Various governments and public-private organizations in countries such as the US, Japan, Germany, the UK, France, China, and India are undertaking initiatives to promote organ donation. These efforts are anticipated to boost transplantation procedures and increase the demand for transplant diagnostic testing.
Challenge: Gap between organ donor availability and transplant demand
The disparity between the availability of organ donors and the demand for transplants presents a significant challenge for the transplant diagnostics market. The number of patients awaiting organ transplants continues to rise globally, while the annual supply of donated organs remains limited. Statistics indicate that nearly 13 people die each day while waiting for an organ transplant. Several factors contribute to the shortage of organ donors, including strict government regulations, insufficient medical reimbursements for living organ donors, and low public awareness about organ donation, especially in developing countries. Additionally, socio-ethical concerns surrounding deceased organ donation further restrict the availability of organs.
TRANSPLANT DIAGNOSTICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Provides PCR- and sequencing-based transplant diagnostic solutions for compatibility and infectious disease testing. | Accurate testing, rapid compatibility assessment, and efficient laboratory workflows. |
 |
Offers automated molecular diagnostic and donor screening solutions for transplantation procedures. | Fast turnaround time, automated workflows, and high-throughput testing. |
 |
Supplies molecular assay technologies and reagents for histocompatibility testing and blood profiling. | Reliable testing, improved precision, and efficient laboratory operations. |
 |
Provides molecular assays and sample preparation solutions for transplant diagnostics. | Efficient sample processing, accurate testing, and streamlined workflows. |
 |
Offers molecular diagnostic and infectious disease testing solutions for transplantation procedures. | Rapid pathogen detection, reliable testing, and improved patient management. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
In the transplant diagnostics market, various stakeholders—including manufacturers, diagnostic laboratories, hospitals, transplant centers, and healthcare providers—collaborate to ensure efficient compatibility testing between donors and recipients, as well as smooth transplantation procedures. Manufacturers develop and supply molecular diagnostic technologies, such as PCR- and sequencing-based assays, which are used for applications like histocompatibility testing, infectious disease testing, and blood profiling. Laboratory personnel and transplant specialists depend on these technologies to conduct accurate and efficient transplant diagnostic procedures. The market is experiencing growth due to technological advancements, ongoing research activities, regulatory support, and partnerships among industry participants.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Transplant Diagnostics Market, by Product & Service
Based on product & service, the transplant diagnostics market is segmented into reagents & consumables, instruments, and software & services. In 2025, the reagents & consumables segment accounted for the largest share of the transplant diagnostics market. The dominance of this segment is mainly attributed to the growing focus on effective and early patient profiling during organ transplantation procedures, increasing adoption of transplant diagnostic techniques in research applications, and the rising number of organ transplantation procedures across major healthcare markets. Furthermore, the extensive use of reagents and consumables in molecular diagnostic techniques such as PCR- and sequencing-based testing for donor-recipient compatibility assessment, histocompatibility testing, and infectious disease testing is further contributing to the growth of this segment.
Transplant Diagnostics Market, by Technology
Based on technology, the transplant diagnostics market is segmented into molecular assays and non-molecular assays. The molecular assay technologies segment is further divided into PCR-based molecular assays and sequencing-based molecular assays. In 2025, the molecular assay technologies segment dominated the transplant diagnostics market. The growth of this segment is primarily attributed to the advantages offered by molecular assays, such as low turnaround time, high procedural efficiency, real-time sample analysis, and the ability to analyze multiple samples simultaneously. In addition, increasing applications in patient profiling, rising public-private investments for product development, growing clinical evidence supporting molecular assay techniques, and technological advancements are further supporting segment growth.
Transplant Diagnostics Market, by Application
Based on application, the transplant diagnostics market is segmented into diagnostic applications and research applications. In 2025, the diagnostic applications segment is expected to witness the fastest growth in the transplant diagnostics market. The growth of this segment is mainly attributed to technological advancements in molecular assay techniques and the increasing adoption of molecular assays for pathogen detection and histocompatibility testing. In addition, the rising prevalence of chronic diseases requiring transplantation and the growing risk of post-transplant infections and genetic disorders are further supporting the demand for transplant diagnostic procedures.
Transplant Diagnostics Market, by Type
Based on type, the transplant diagnostics market is segmented into solid organ transplantation, stem cell transplantation, soft tissue transplantation, and bone marrow transplantation. In 2025, the solid organ transplantation segment accounted for the largest share of the transplant diagnostics market. The dominance of this segment is mainly attributed to the increasing demand for donor-recipient compatibility testing, infectious disease testing, histocompatibility testing, genomic profiling, and blood profiling during solid organ transplantation procedures. In addition, the rising number of organ transplantation procedures, supportive government initiatives, increasing prevalence of chronic diseases requiring transplantation, and technological advancements in transplant diagnostics are further supporting the growth of this segment.
Transplant Diagnostics Market, by End User
Based on end user, the transplant diagnostics market is segmented into hospitals & transplant centers, research laboratories & academic institutes, and independent reference laboratories. In 2025, the independent reference laboratories segment dominated the transplant diagnostics market. The growth of this segment is mainly attributed to the increasing modernization and automation of diagnostic laboratories, rising outsourcing of research activities by pharmaceutical and biotechnology companies, and growing demand for infectious disease diagnosis and tissue typing during donor-recipient profiling and cross-matching procedures.
REGION
North America accounted for largest share of global transplant diagnostics market during forecast period.
In North America, several factors have influenced the growth of the transplant diagnostics market. These include the availability of advanced transplant diagnostic technologies, well-developed healthcare infrastructure, and increasing adoption of molecular diagnostic techniques. Other factors include growing public-private investments in transplant diagnostic research, government initiatives supporting genome-based medical diagnosis, and the presence of major industry participants. Rising demand for donor-recipient compatibility testing, increasing awareness regarding transplantation procedures, and the growing need for accurate diagnostic testing are some of the other factors supporting market growth in the region.
TRANSPLANT DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX
Thermo Fisher Scientific Inc. (US) is one of the key participants in the transplant diagnostics market with a diverse portfolio of molecular diagnostic technologies and transplant testing solutions. The company offers PCR- and sequencing-based technologies for donor-recipient compatibility testing, histocompatibility testing, infectious disease testing, and blood profiling during transplantation procedures. Geographically, Thermo Fisher Scientific has a strong presence across North America, Europe, and Asia Pacific, where it provides transplant diagnostic solutions to hospitals, transplant centers, diagnostic laboratories, and research institutes. The company focuses on technological advancements and continuous product development to improve the efficiency, accuracy, and reliability of transplant diagnostic procedures. In addition, its strong global distribution network and strategic collaborations further support its position in the transplant diagnostics market.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 5.25 Billion |
| Market Forecast in 2026 (Value) | USD 5.61 Billion |
| Market Forecast in 2031 (Value) | USD 8.14 Billion |
| CAGR | CAGR of 7.8% from 2026-2031 |
| Years Considered | 2024-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD Million/Billion) |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, the Middle East & Africa |
WHAT IS IN IT FOR YOU: TRANSPLANT DIAGNOSTICS MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Product Analysis | ? Product matrix, which provides a detailed comparison of the product portfolio of each company in the transplant diagnostics market | Enables easy comparison of competitors’ offerings, helping identify gaps, overlaps, and differentiation opportunities. |
| Company Information | ? Additional five company profiles of players operating in the transplant diagnostics market. | Provides insights into competitors’ strategies, innovation focus, and partnerships, supporting strategic planning. |
RECENT DEVELOPMENTS
- October 2024 : QIAGEN N.V. (Netherlands) expanded its automated liquid biopsy portfolio to support oncology, prenatal care, and organ transplant applications. The portfolio expansion was aimed at improving automated workflows and molecular diagnostic procedures used in organ transplantation.
- October 2024 : Werfen (Spain) completed the acquisition of Omixon (Hungary), a company focused on next-generation sequencing (NGS)-based transplant diagnostic technologies. Through this acquisition, Werfen expanded its transplant diagnostics portfolio for hospitals and clinical laboratories.
- March 2026 : F. Hoffmann-La Roche Ltd. (Switzerland) launched the cobas MPX-E assay, a 4-in-1 donor screening test designed to detect HIV, HCV, HBV, and HEV in a single test. The assay is intended to improve laboratory efficiency, reduce turnaround time, and support high-throughput donor screening workflows.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
The objective of this study is to analyze the key market dynamics, including drivers, opportunities, constraints, challenges, and strategies employed by key players. We will track developments within companies, such as acquisitions, product launches, expansions, agreements, and partnerships, to assess the competitive landscape of the transplant diagnostics market. This analysis will evaluate market players across various parameters within the broader categories of business and product strategy.
To estimate the market size, both top-down and bottom-up approaches were utilized. The market breakdown and data triangulation were employed to determine the sizes of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives at key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess prospects.
The following is the breakdown of primary respondents:
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
|
COMPANY NAME |
DESIGNATION |
|
Thermo Fisher Scientific Inc. (US) |
Sales Manager |
|
F. Hoffmann-La Roche AG (Switzerland) |
Product Manager |
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the transplant diagnostics market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research.
- The revenues generated by leading players operating in the transplant diagnostics market have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Transplant Diagnostics Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Transplant diagnostic procedures are used to determine donor-recipient compatibility to avoid the risk of immune rejection in a recipient. These procedures are adopted for donor-recipient cross-matching, subject profiling, genotyping, and other related diagnostic tests. Advanced genomic techniques (such as PCR and NGS) are increasingly being used during transplant diagnostic procedures, apart from serological and other conventional techniques for immuno-compatibility testing (such as antibody-antigen reaction and leucocyte assay).
Key Stakeholders
- To define, segment, and forecast the transplant diagnostics market by product & service, technology, application, type, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
- To study the impact of AI on the market, along with the macroeconomic outlook for each region
Report Objectives
- To define, segment, and forecast the transplant diagnostics market by product & service, technology, application, type, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
- To study the impact of AI on the market, along with the macroeconomic outlook for each region
Available customizations:
MarketsandMarkets offers the following customizations for this market report.
Product Analysis
-
Product matrix, which provides a detailed comparison of the product portfolio of each company in the transplant diagnostics market
Country Information
-
Product matrix, which provides a detailed comparison of the product portfolio of each company in the transplant diagnostics market
Company Profiles
-
Product matrix, which provides a detailed comparison of the product portfolio of each company in the transplant diagnostics market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Transplant Diagnostics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free CustomisationTESTIMONIALS
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Companywww.sfihealth.com/
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Companywww.qualicaps.com/
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnosticsimaging.bracco.com/us-en
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.www.3m.com/3M/en_US/health-information-systems-us
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
Growth opportunities and latent adjacency in Transplant Diagnostics Market